163 related articles for article (PubMed ID: 16677365)
21. Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS.
Dharnidharka VR; Talley LI; Martz KL; Stablein DM; Fine RN
Pediatr Transplant; 2008 Sep; 12(6):689-95. PubMed ID: 18179637
[TBL] [Abstract][Full Text] [Related]
22. [Controversies about the use of calcineurin inhibitors in pediatric patients].
Dello Strologo L
G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
[TBL] [Abstract][Full Text] [Related]
23. Rejection versus posttransplantation lymphoproliferative disorder in a renal transplant recipient.
Troxell ML; Dunlap JB; Mittalhenkle A; Ishag M; Fan G; Huang JZ; Gatter K; Byrd DM; Webster D; Houghton DC
Am J Kidney Dis; 2008 Dec; 52(6):1174-9. PubMed ID: 18706749
[No Abstract] [Full Text] [Related]
24. Renal transplantation outcomes: a comparative analysis between elderly and younger recipients.
Mendonça HM; Dos Reis MA; de Castro de Cintra Sesso R; Câmara NO; Pacheco-Silva A
Clin Transplant; 2007; 21(6):755-60. PubMed ID: 17988270
[TBL] [Abstract][Full Text] [Related]
25. Post-transplant lymphoproliferative disorders of oral cavity.
Ojha J; Islam N; Cohen DM; Marshal D; Reavis MR; Bhattacharyya I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):589-96. PubMed ID: 18442744
[TBL] [Abstract][Full Text] [Related]
26. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
Azarpira N; Torabineghad S; Rakei M
Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
[TBL] [Abstract][Full Text] [Related]
27. Recurrent pancreatitis after renal transplantation in a child.
Cho MH; Hong EH; Lee HS; Ko CW
Pediatr Transplant; 2008 Aug; 12(5):593-6. PubMed ID: 18397214
[TBL] [Abstract][Full Text] [Related]
28. Pediatric transplant grand rounds.
Benfield MR; Harmon WE
Pediatr Transplant; 1997 Aug; 1(1):65-72. PubMed ID: 10084789
[No Abstract] [Full Text] [Related]
29. A case of living-related renal transplant from the donor with membranous nephropathy.
Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia.
Valentini RP; Imam A; Warrier I; Ellis D; Ritchey AK; Ravindranath Y; Shapiro R; Moritz ML
Pediatr Transplant; 2006 May; 10(3):358-61. PubMed ID: 16677361
[TBL] [Abstract][Full Text] [Related]
31. Estimated one-yr glomerular filtration rate is an excellent predictor of long-term graft survival in pediatric first kidney transplants.
Muscheites J; Wigger M; Drueckler E; Klaassen I; John U; Wygoda S; Fischer DC; Kundt G; Misselwitz J; Müller-Wiefel DE; Haffner D
Pediatr Transplant; 2009 May; 13(3):365-70. PubMed ID: 18537896
[TBL] [Abstract][Full Text] [Related]
32. Calciphylaxis-associated second renal graft failure and patient loss: a case report and review of the literature.
Aabed G; Al Furayh O; Al-Lehbi A; Al Mana H; Al Ghamedi A; Helmy A
Exp Clin Transplant; 2008 Dec; 6(4):287-93. PubMed ID: 19338491
[TBL] [Abstract][Full Text] [Related]
33. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
Katz BZ; Pahl E; Crawford SE; Kostyk MC; Rodgers S; Seshadri R; Proytcheva M; Pophal S
Pediatr Transplant; 2007 Feb; 11(1):58-65. PubMed ID: 17239124
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
[TBL] [Abstract][Full Text] [Related]
35. Post renal transplant Castleman's disease resolved after graft nephrectomy: a case report.
Al Otaibi T; Al Sagheir A; Ludwin D; Meyer R
Transplant Proc; 2007 May; 39(4):1276-7. PubMed ID: 17524952
[TBL] [Abstract][Full Text] [Related]
36. [Bilateral papillary renal cell carcinoma in a patient post-renal transplantation].
Jobs K; Kluge P; Kościesza A; Dembowska-Bagińska B; Grenda R
Przegl Lek; 2006; 63 Suppl 3():187-8. PubMed ID: 16898526
[TBL] [Abstract][Full Text] [Related]
37. Outcome after kidney transplantation in children with thrombotic risk factors.
Kranz B; Vester U; Nadalin S; Paul A; Broelsch CE; Hoyer PF
Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing long-term outcomes following renal transplantation: a review.
Shrestha BM; Haylor JL
JNMA J Nepal Med Assoc; 2007; 46(167):136-42. PubMed ID: 18274571
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of pediatric renal transplantation: the Norwegian experience in three eras 1970-2006.
Tangeraas T; Bjerre A; Lien B; Kyte A; Monn E; Cvancarova M; Leivestad T; Reisaeter AV
Pediatr Transplant; 2008 Nov; 12(7):762-8. PubMed ID: 18208441
[TBL] [Abstract][Full Text] [Related]
40. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
Brunner B; Kropshofer G; Ellemunter H; Brunner A; Mueller T; Margreiter R; Tzankov A
Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
